Cargando…
Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis
Aspartate aminotransferase-to-platelet ratio index (APRI) and Fibrosis-4 Index (Fib4) have been validated against liver biopsy for detecting advanced hepatic fibrosis in HFE hemochromatosis. We determined the diagnostic utility for advanced hepatic fibrosis of Hepascore and transient elastography co...
Autores principales: | Ong, Sim Yee, Khoo, Tiffany, Nicoll, Amanda J., Gurrin, Lyle, Worland, Thomas, Pateria, Puraskar, Ramm, Louise E., Testro, Adam, Anderson, Gregory J., Skoien, Richard, Powell, Lawrie W., Ramm, Grant A., Olynyk, John K., Delatycki, Martin B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289828/ https://www.ncbi.nlm.nih.gov/pubmed/34282177 http://dx.doi.org/10.1038/s41598-021-94083-x |
Ejemplares similares
-
Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis
por: Chin, Justin, et al.
Publicado: (2019) -
The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis
por: Olynyk, John K., et al.
Publicado: (2023) -
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)
por: Ong, Sim Yee, et al.
Publicado: (2015) -
Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver
por: Crawford, Darrell H. G., et al.
Publicado: (2023) -
Non-HFE hemochromatosis
por: Santos, Paulo Caleb Júnior de Lima, et al.
Publicado: (2012)